HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Hydroxyamphetamine Hydrobromide

HCID 9377
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
140-36-3
Standard SMILES
Br.CC(N)Cc1ccc(O)cc1
InChIKey
RZCJLMTXBMNRAD-UHFFFAOYSA-N
Molecular formula
C9H14BrNO
Average molar mass
232.12 g/mol
Monoisotopic mass
231.02588

Overview

Hydroxyamphetamine Hydrobromide is the hydrobromide salt form of hydroxyamphetamine, an indirect-acting sympathomimetic amine with adrenergic properties. Hydroxyamphetamine, when applied topically to the eye, stimulates the release of norepinephrine from postganglionic adrenergic nerves resulting in the stimulation of both alpha and beta adrenergic receptors. Local alpha stimulatory effects include dilation of the pupil, increased flow of aqueous humor, and vasoconstriction; whereas beta stimulatory effects include relaxation of the ciliary muscle and a decreased production in aqueous humor.

Names & identifiers

Preferred name
Hydroxyamphetamine Hydrobromide
IUPAC
4-(2-aminopropyl)phenol;hydrobromide

Names & synonyms

HYDROXYAMPHETAMINE HYDROBROMIDE306-21-8ParedrinePredrolonhydroxyamfetamine hydrobromideHydroxyamfetamine hbrHydroxyamphetamine hbrDTXSID0045961Phenol, 4-(2-aminopropyl)-, hydrobromideNSC-6106559IG47SZ0EPhenol, 4-(2-aminopropyl)-, hbr
Show more names
beta-(p-Hydroxyphenyl)isopropylamine hydrobromideDTXCID8025961NSC61065Hydroxyamphetamine hydrobromide (USP)Hydroxyamphetamine hydrobromide [USP]RefChem:56591Hydrobromide, Hydroxyamphetamine206-181-4

Database identifiers

CAS
140-36-3、306-21-8
PubChem CID
9377
DTXSID
DTXSID0045961
ChEMBL
CHEMBL1200705
UNII
59IG47SZ0E
EC Number
206-181-4

Properties

Computed structural properties

Topological polar surface area
46.3 Ų
Hydrogen bond donors
3
Hydrogen bond acceptors
2
Rotatable bonds
2
Heavy atoms
12
Formal charge
0
Complexity
108

Experimental & physicochemical properties

Human Drugs · 2 items

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H300+H330 (33.3%): Fatal if swallowed or if inhaled [Danger Acute toxicity, oral; acute toxicity, inhalation]

P203, P260, P261, P264, P264+P265, P270, P271, P280, P284, P301+P316, P301+P317, P302+P352, P304+P340, P305+P351+P338, P316, P318, P319, P320, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 3 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Hazard Classes and CategoriesAcute Tox. 2 (33.3%)

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 2 items

Agents that dilate the pupil. They may be either sympathomimetics or parasympatholytics.

Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters.

Related reactions

2 records
New reaction record
HRID 441573 reaction equation
HRID 441573As reactant
HRID 1709274 reaction equation
HRID 1709274As reactant

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes